Evidence map›Paper›PMID 28819029›Full record

ArticleCancer research2017

Loss of Tumor Suppressor

Zharko Daniloski, Susan Smith

Abstract read
In one paragraph

Article in Cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Alternative Lengthening of Telomeres: The Need forInternational journal of molecular sciences · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Defining a core configuration for human centromeres during mitosis.bioRxiv : the preprint server for biology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The multifaceted roles of cohesin in cancer.Journal of experimental & clinical cancer research : CR · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zharko DaniloskiDepartment of Pathology, Kimmel Center for Biology and Medicine at the Skirball Institute, New York University School of Medicine, New York, New York.
Susan SmithDepartment of Pathology, Kimmel Center for Biology and Medicine at the Skirball Institute, New York University School of Medicine, New York, New York. susan.smith@med.nyu.edu.
New York University · US

Funding

Regulation of telomere recombination in ALT cancer cellsR01CA200751 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SMITH, SUSAN · 2016 to 2020
$2.0M
NCI NIH HHS R01 CA200751
6 · The paper itself

Abstract

Sister chromatids are held together by cohesin, a tripartite ring with a peripheral SA1/2 subunit, where SA1 is required for telomere cohesion and SA2 for centromere cohesion. The

Indexed as

Genes, Tumor SuppressorRecombination, GeneticAntigens, NuclearCell Cycle ProteinsCell Line, TumorCell SurvivalCohesinsHCT116 CellsHeLa CellsHumansNeoplasmsTelomereAntigens, NuclearCell Cycle ProteinsCohesinsSTAG2 protein, human

Identifiers

PMID28819029
PMCPMC5645240
OpenAlexW2746280574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.